Certain Infectious and Parasitic Diseases

Codes Discussed: A30-A49 (Other bacterial diseases), B20 (Human immunodeficiency virus disease/AIDS), U07.1 (COVID-19), U09.9 (Post COVID-19 condition), A18.83 (Tuberculosis of digestive tract, not elsewhere classified), A18.32 (Tuberculosis of intestine), B15-B19 (Viral hepatitis), B25.1 (Cytomegaloviral hepatitis), B00.81 (Herpesviral hepatitis), L03.011 (Cellulitis of right finger), B95.61 (Staphylococcus aureus as the cause of diseases classified elsewhere), A41.9 (Sepsis, unspecified organism), R65.2 (Severe sepsis category), R65.20 (Severe sepsis without septic shock), R65.21 (Severe sepsis with septic shock), B95 (Streptococcus, Staphylococcus, and Enterococcus as the cause of diseases classified elsewhere), B96 (Other bacterial agents as the cause of diseases classified elsewhere), J13 (Pneumonia due to Streptococcus pneumoniae), K29.70 (Gastritis, unspecified, without bleeding), B96.81 (Helicobacter pylori as the cause of diseases classified elsewhere), A04.8 (Other specified bacterial intestinal infections), L00-L08 (Infections of the skin and subcutaneous tissue), B95.62 (Methicillin resistant Staphylococcus aureus infection as the cause of diseases classified elsewhere), Z16 (Resistance to antimicrobial drugs category), Z16.21 (Resistance to vancomycin), Y95 (Nosocomial condition), Z21 (Asymptomatic human immunodeficiency virus infection status), Z86.19 (Personal history of other infectious and parasitic diseases), B18 (Chronic viral hepatitis category), B34.9 (Viral infection, unspecified), B37 (Candidiasis category), B37.1 (Pulmonary candidiasis), B37.7 (Candidal sepsis), B37.9 (Candidiasis, unspecified), O98.5 (Other viral diseases complicating pregnancy, childbirth, and the puerperium), P35.8 (Other congenital viral diseases), Z38 (Liveborn infants according to place of birth and type of delivery), M35.81 (Multisystem inflammatory syndrome), Z20.822 (Contact with and suspected exposure to COVID-19), Z11.52 (Encounter for screening for COVID-19), Z01.84 (Encounter for antibody response examination), Z86.16 (Personal history of COVID-19), Z23 (Encounter for immunization), Z28.3 (Underimmunization status category), Z28.311 (Partially vaccinated for COVID-19), J15.1 (Pneumonia due to Pseudomonas), A41.50 (Gram-negative sepsis, unspecified), A02.9 (Salmonella infection, unspecified), A04.72 (Enterocolitis due to Clostridium difficile, not specified as recurrent), A41.02 (Sepsis due to Methicillin resistant Staphylococcus aureus), J15.211 (Pneumonia due to Methicillin susceptible Staphylococcus aureus), J15.212 (Pneumonia due to Methicillin resistant Staphylococcus aureus), L03.90 (Cellulitis, unspecified), L03.311 (Cellulitis of abdominal wall), B95.2 (Enterococcus as the cause of diseases classified elsewhere), I33.0 (Acute and subacute infective endocarditis), B95.5 (Unspecified streptococcus as the cause of diseases classified elsewhere), J15.9 (Unspecified bacterial pneumonia), Z16.24 (Resistance to multiple antibiotics), N39.0 (Urinary tract infection, site not specified), B96.20 (Unspecified Escherichia coli as the cause of diseases classified elsewhere), N28.9 (Disorder of kidney and ureter, unspecified), A41.51 (Sepsis due to Escherichia coli), A49.8 (Other bacterial infections of unspecified site), T80.211A (Bloodstream infection due to central venous catheter, initial encounter), D61.818 (Other pancytopenia), L03.115 (Cellulitis of right lower limb), J96.01 (Acute respiratory failure with hypoxia), R05.9 (Cough, unspecified), R50.9 (Fever, unspecified), R43.8 (Other disturbances of smell and taste), B02.30 (Zoster ocular disease, unspecified), B02.39 (Other herpes zoster eye disease), B02.9 (Zoster without complications), J18.9 (Pneumonia, unspecified organism), A49.02 (Methicillin resistant Staphylococcus aureus infection, unspecified site), A41.81 (Sepsis due to Enterococcus), J96.00 (Acute respiratory failure, unspecified whether with hypoxia or hypercapnia)

Topics Covered: ICD-10-CM infectious and parasitic diseases coding, ICD-10-CM Chapter 1 coding, bacterial infection coding, viral infection coding, fungal infection coding, parasitic disease coding, infectious etiologies, microorganisms that cause infection, bacteria shapes, cocci, bacilli, curved bacteria, spiral bacteria, diplococcal bacteria, tetrads, streptococci, staphylococci, spirochetes, vibrios, gram-positive bacteria, gram-negative bacteria, gram staining, aerobic bacteria, anaerobic bacteria, pathogen identification, viruses, virions, RNA viruses, DNA viruses, latent viruses, fungal infections, yeast infections, mold infections, superficial fungal infections, athlete’s foot, vaginal yeast infection, San Joaquin fever, parasites, roundworms, flukes, tapeworms, protozoa, amoebas, infectious disease testing, complete blood count, CBC testing, blood culture, sputum culture, urine culture, culture and sensitivity, chest x-ray for infection, antibody testing, viral antigen detection, viral culture, viral DNA testing, viral RNA testing, lumbar puncture, titers, fungal blood cultures, wound cultures, CSF testing, fecal O and P testing, endoscopy for parasites, colonoscopy for parasites, serology, blood smears, infectious disease pharmacology, antibiotics, antiviral symptom treatment, anthelmintic drugs, antifungal medication, fluconazole, miconazole, ICD-10-CM A codes, ICD-10-CM B codes, Chapter 22 codes for special purposes, COVID-19 coding, post COVID-19 condition coding, Excludes1 notes, Excludes2 notes, infectious agents as cause of diseases classified elsewhere, causative organism coding, cellulitis due to Staphylococcus aureus, sepsis coding, severe sepsis coding, septic shock coding, Sepsis-2 criteria, Sepsis-3 criteria, SOFA score, qSOFA score, systemic inflammatory response to infection, acute organ dysfunction, sepsis documentation requirements, severe sepsis documentation requirements, sepsis sequencing, localized infection with sepsis, postprocedural sepsis coding, postprocedural septic shock coding, bacterial infection coding guidelines, E. coli infection coding, E. coli UTI coding, urinary tract infection causative organism coding, streptococcal pneumonia coding, Helicobacter pylori gastritis coding, antimicrobial resistance coding, antibiotic resistance coding, methicillin-resistant Staphylococcus aureus coding, MRSA coding, methicillin-susceptible Staphylococcus aureus coding, MSSA coding, healthcare-associated MRSA, community-associated MRSA, MRSA pneumonia coding, MRSA sepsis coding, MRSA cellulitis coding, drug-resistant organism coding, carbapenem-resistant Enterobacteriaceae, CRE infection, vancomycin-resistant organism coding, VRSA coding, VRE coding, resistance to multiple antibiotics, nosocomial infection coding, hospital-acquired infection coding, HIV coding, AIDS coding, asymptomatic HIV status coding, HIV-related illness coding, opportunistic infection coding, pneumocystis carinii pneumonia, viral hepatitis coding, acute hepatitis coding, chronic hepatitis coding, hepatitis B coding, hepatitis C coding, hepatitis carrier status, history of hepatitis coding, viral syndrome coding, candidiasis coding, candidal pneumonia coding, candidal sepsis coding, COVID-19 confirmed case coding, COVID-19 provider documentation, COVID-19 sequencing guidelines, COVID-19 manifestations coding, pneumonia due to COVID-19 coding, sepsis due to COVID-19 coding, COVID-19 in pregnancy coding, COVID-19 in newborns coding, congenital COVID-19 coding, multisystem inflammatory syndrome coding, MIS coding, COVID-19 exposure coding, COVID-19 screening coding, COVID-19 antibody testing coding, history of COVID-19 coding, long COVID coding, COVID-19 vaccination coding, underimmunization for COVID-19 coding, partially vaccinated for COVID-19 coding, Code Purple practice, Code Red assessment, infectious disease coding scenarios